Superior Mesentraic Artery Thrombosis - Single Unit Experience During the COVID- 19 Pandemic

Author(s): Saugata Sammadar, Bageshwar Kuamr, Rajender Meena, Gopal Puri, Ankita Singh, Piyush Ranjan

The Corona Virus Disease 2019 (COVID-19) pandemic caused by novel coronavirus primarily causing infection of lower respiratory tract since December 2019 has been leading cause of mortality and morbidity. With this unpredicted health emergency the number of ischemia related health events has also seen sudden rise, be it cardiovascular disease, stroke, acute limb ischemia and acute thrombo-embolic arterial and venous insult to the gastrointestinal system [1,2]. Acute thrombo-embolic occlusion of the Superior Mesenteric Artery (SMA) is uncommon condition with high mortality rates. High Mortality rate can be attributed to low preoperative diagnostic accuracy and limited timely therapeutic options [3]. The mode of diagnosis has shifted from autopsy to laparotomy and multidetector computer tomography in last couple of decades. Nonocclusive mesenteric ischemia (NOMI) leading to transmural intestinal infraction is a condition with extremely high mortality. Despite the considerable advances in the diagnosis and treatment, cause of mesenteric ischemic by enlarge remains elusive. This case series is aimed to provide valuable insight into to presentation ad outcome during COVID.